Direct answer: an eye balm stick OEM project needs one approval record for the solid formula and its twist-up package. Compare the exposed balm, moving platform, barrel and cap together. Then connect glide, deposited feel, hygienic handling and migration questions to the intended use and safety assessment. A smooth swipe from an open sample is insufficient grounds to approve the filled retail pack.
Prepared 8 September 2026. This is a factory-side development guide based on a current source-format review and established primary safety information checked today. It does not report a new market trend, demand increase or completed GUOCUI test.
The illustration shows a proposed development sample. It is AI-generated and is not a photograph of a finished product, factory, laboratory or completed QC work.
Define the Solid Before Choosing the Decoration
A balm stick has a self-supporting solid exposed above a rigid barrel. That differs from a cream squeezed through a ceramic-tip tube or an eye serum measured through a pump. The moving platform must support the solid through extension, use, retraction and closure. Texture and mechanism therefore belong in the same sample round.
Start with a simple sentence describing the intended external skin-care use and audience. Keep ocular application and broken skin outside this concept. Ingredient selection, application boundaries and final directions require qualified review before in-use evaluation. FDA’s eye-cosmetic guidance makes intended use, clean handling and applicator care relevant starting points; it does not approve this proposed formula or pack.
Decision 1: Contact Face and Exposed Height
Ask the component supplier for the dimensions that affect contact: balm diameter, top profile, barrel edge and the amount that can project beyond the collar. A catalogue photograph may hide the platform and usable clearance. Request a drawing or component sample before committing to an outer-box layout.
During controlled material handling, record the exposed height and test surface. Too many variables changing together make feedback difficult to interpret. A different top shape may change the contact pattern even when the formula is unchanged. Treat that as a design question, not an automatic improvement.
Decision 2: Extension, Retraction and Cap Clearance
Check whether the filled solid moves with the platform, tilts inside the barrel or leaves material on the collar. Observe the first movement and repeated opening sequence. Record skipped movement, unexpected resistance, sticking or surface damage by sample code.
Close the cap in the intended storage position and inspect for contact with the balm. If product reaches the inner cap, distinguish excess extension from an unsuitable cap cavity or a deformed solid. Changing the label cannot resolve a mechanical mismatch.
Decision 3: Glide, Deposit and Transfer
Begin with material comparisons on an agreed inert surface. Keep exposed height, stroke method and observation conditions consistent. Note drag, crumbling, discontinuous streaks, visible film and transfer after contact with another clean surface. These observations help distinguish a structure problem from an unsuitable component.
Human-use or tolerance evaluation requires an appropriate reviewed protocol. Once authorized, the assessment should address the proposed placement and whether material moves beyond it. Do not use an attractive hand swatch as proof of eye-area suitability, or translate a low-residue observation into a guaranteed wear claim.
Decision 4: Handling and Formula Protection
Agree how development samples are assigned, opened, stored and kept separate from retail testers. Repeated direct contact changes the questions that a formula and packaging assessment must answer. The cap, collar and exposed surface should be considered together with the intended instructions.
FDA’s microbiological-safety overview identifies ingredients, manufacturing, preservation, packaging, storage and consumer use as possible contamination routes. A solid appearance or dry leak check does not establish microbial protection. Ask the qualified assessor which information and testing are needed for the actual composition and use.
Decision 5: Storage Changes in the Filled Pack
Retain filled samples in the proposed component alongside the formula reference. The review plan can observe sweating, shrinkage, cracking, odour, colour, platform grip and closure condition under agreed conditions. Note whether a change appears in the bulk material, only at the barrel wall or after closure.
FDA’s shelf-life explanation describes how storage, use and environmental exposure can affect cosmetic condition. It supplies background, not a ready-made shelf life or test temperature for this balm. Set the project protocol and supporting evidence before putting a duration on artwork.
Decision 6: Separate Safety Evidence from Sensory Approval
A buyer can like the glide while the formula review remains unfinished. Keep those decisions in separate fields. Request ingredient identity, supplier documentation and the proposed instructions; identify evidence gaps with a qualified assessor before deciding what additional work is required.
FDA’s product-testing guidance explains the role of available safety data and further testing where needed. Botanical origin alone does not establish safety. Avoid transferring another product’s cooling language, ingredient percentages or clinical figures to a new solid formula.
Decision 7: Quote the Approved Combination
Build the RFQ around a formula route, component code, decoration, carton, languages and quantity split. Include one acceptable standard-pack option if the preferred component is still under review. Separate formula revisions, component sourcing, artwork and documentation milestones so the export team can explain what affects the schedule.
| Approval record | What must remain connected |
|---|---|
| Material | Formula reference, solid appearance, glide observations and assessment gaps. |
| Mechanism | Component code, exposed height, platform movement and cap clearance. |
| Release planning | Reviewed instructions, label version, pack-out and outstanding decisions. |
GUOCUI BIO TECH / Guangzhou Guocui Biological Technology Co., Ltd. can coordinate formula discussion, coded samples, packaging selection, label localization and QC communication. MOQ, quotation and sample or production timing follow the selected formula, pack and order plan. No finished safety result, fixed capacity or commercial commitment is established by this guide.
Frequently Asked Questions
Can an existing lip-balm stick be relabelled for eye-area use?
Its previous use does not establish suitability for another area. Review the actual formula, component, intended use and directions before approving an eye-area project.
Should I choose the solid formula or pack first?
Shortlist them together. A formula sample outside its barrel cannot show platform grip, retraction, cap contact or filled-pack storage behaviour.
Does an anhydrous direction remove the need for assessment?
No. The composition, handling, package and intended use determine the evidence needed. A format description alone cannot settle safety or protection questions.
Can glide and migration use the same approval field?
Keep them separate. Glide describes handling and deposit; migration concerns where material moves under a defined evaluation. Neither alone establishes safety.
What should a buyer send first?
Send the destination market, intended use, texture preference, component idea, quantity range, label languages and sample priorities. Identify claims or documents requiring review.
Start with the Private Label Eye-Area Balm Stick, explore Products and Eye Care, or review Customization. The existing liquid eye-serum guide covers a different dispensing route. Send a balm-stick sample brief when these decisions are ready to discuss.
Leave a Reply